Justin Norden is the co-founder and CEO of Qualified Health, an enterprise AI platform helping U.S. health systems deploy generative AI safely, with governance, monitoring, and clinical safeguards built in. A Stanford-trained physician with an MBA, an MPhil in computational biology from Cambridge, and a computer science degree from Carleton, he previously was a partner at GSR Ventures investing in healthcare AI, founded Trustworthy AI (acquired by Waymo), worked on Apple's healthcare team, and teaches AI in medicine at Stanford. In March 2026 Qualified Health raised a $125M Series B led by NEA, bringing total funding to $155M while serving 500,000+ users across systems representing roughly 7% of U.S. hospital revenue.
Maureen Hillenmeyer is the founder and CEO of Hexagon Bio, a Menlo Park drug-discovery company that mines the genomes of fungi for hidden small molecules and engineers yeast to brew them into potential medicines. A former competitive swimmer turned computational biologist, she holds a PhD in biomedical informatics from Stanford and built the company out of a Stanford research program she led, raising more than $270 million to turn DNA sequence data into cancer and infectious-disease therapeutics.